Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]
2006

Lutein Supplementation in Retinitis Pigmentosa

Sample size: 34 publication 10 minutes Evidence: moderate

Author Information

Author(s): Bahrami Hossein, Melia Michele, Dagnelie Gislin

Primary Institution: The Wilmer Eye Institute, Johns Hopkins University

Hypothesis

Does lutein supplementation preserve visual function in patients with retinitis pigmentosa?

Conclusion

Lutein supplementation may improve visual field and slightly enhance visual acuity, but results should be interpreted cautiously.

Supporting Evidence

  • Lutein supplementation improved visual field significantly.
  • Visual acuity improvements were not statistically significant.
  • The study was the first randomized placebo-controlled trial of lutein in retinitis pigmentosa.

Takeaway

This study looked at whether taking lutein helps people with a vision problem called retinitis pigmentosa see better. It found that lutein might help a little, especially with seeing in the side of your vision.

Methodology

A double-masked randomized placebo-controlled phase I/II clinical trial with a crossover design.

Potential Biases

Potential confounding effects from multivitamin use and the small sample size may limit the generalizability of the results.

Limitations

The study had a small sample size and a short follow-up duration.

Participant Demographics

34 adult patients with retinitis pigmentosa, including 21 women and 13 men, mean age 49.2 years.

Statistical Information

P-Value

0.038

Confidence Interval

95% CI: 0.001, 0.036

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2415-6-23

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication